Die Komplexität der SARS-CoV-2-Infektion im klinischen Alltag der Geburtshilfe – Auseinandersetzung anhand eines Fallbeispiels

Zusammenfassung

Seit Beginn der Pandemie dominiert die SARS-CoV-2-Infektion den klinischen Alltag. In der Behandlung von Hochrisikopopulationen bestand lange Unklarheit über das Ausmaß und die Konsequenzen der Infektion. Zu diesem Risikokollektiv gehört auch die schwangere Patientin. Die Etablierung von klinischen Registerstudien konnte innerhalb kürzester Zeit und unter enormer Anstrengung zu einer Einschätzung der pandemischen Lage für dieses Kollektiv beitragen. Anhand eines klinischen Falls wird im folgenden Bericht die Assoziation zwischen SARS-CoV-2-Infektion einer schwangeren Patientin mit klinischen Zeichen der Präeklampsie bis hin zur Ausbildung eines posterioren reversiblen Enzephalopathiesyndroms (PRES) beschrieben. Anhand des Falles wird die differentialdiagnostische Abklärung zwischen fulminanten Verlauf der Infektion und Präeklampsie dargelegt. Der Artikel stellt die aktuelle Datenlage zum Auftreten eines PRES in der Schwangerschaft im Zusammenhang mit einer SARS-CoV-2-Infektion dar und setzt sich mit möglichen Differentialdiagnosen auseinander. Durch die interdisziplinäre Betreuung der Patientin kann eine Übersicht zu den Aspekten des jeweiligen Fachgebietes dargelegt werden.

Abstract

Since the beginning of the pandemic, SARS-CoV-2 infection has dominated clinical practice. In the treatment of high-risk populations, there has long been uncertainty about the extent and consequences of infection. This high-risk population includes pregnant patients. The establishment of clinical registry studies was able to contribute an assessment of the pandemic situation for this collective within a very short time and with enormous effort. Based on a clinical case, the following report describes the association between SARS-CoV-2 infection of a pregnant patient with clinical signs of preeclampsia to the development of posterior reversible encephalopathy syndrome (PRES). Based on the case, the differential diagnostic workup between fulminant course of infection and preeclampsia is presented. The article presents the current data on the occurrence of PRES in pregnancy in the context of SARS-CoV-2 infection and addresses possible differential diagnoses. Interdisciplinary care of the patient allows an overview of aspects of each specialty to be presented.

Schlüsselwörter

Schwangerschaft - Präeklampsie - Sars-CoV2-Infektion - Posteriores reversibles Enzephalopathie-Syndrom (PRES)

Key words

pregnancy - preeclampsia - Sars-CoV2-Infection - Posterior reversible Encephalopathie Syndrome (PRES)

Publication History

Received: 10 May 2022

Accepted after revision: 12 July 2022

Article published online:
01 September 2022

• Literatur

• 1 Harrison AG, Lin T, Wang P. Mechanisms of SARS-CoV-2 Transmission and Pathogenesis. Trends Immunol 2020; 41: 1100-1115 DOI: 10.1016/j.it.2020.10.004.
• 2 Tolebeyan AS, Zhang N, Cooper V. et al. Headache in Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection: A Narrative Review. Headache. 2020; 60: 2131-2138 DOI: 10.1111/head.13980.
• 3 Jin X, Lian JS, Hu JH. et al. Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptoms. Gut 2020; 69: 1002-1009 DOI: 10.1136/gutjnl-2020-320926.
• 4 Deutsche Gesellschaft für Allgemeinmedizin und Familienmedizin e.V. ((DEGAM). S2e-Leitlinie. AWMF-Register-Nr. 053-054. SARS-CoV-2/Covid-19- Informationen & Praxishilfen für niedergelassene Hausärztinnen und Hausärzte. Im Internet: https://www.awmf.org/uploads/tx_szleitlinien/053-054l_S2e_SARS-CoV-2-Covid-19-Informationen-Praxishilfen-Hausaerztinnen-Hausaerzte_2022-02_2.pdf Stand: 13.06.2022
• 5 Rana S, Lemoine E, Granger JP. et al. Preeclampsia: Pathophysiology, Challenges, and Perspectives. Circ Res 2019; 124: 1094-1112 DOI: 10.1161/CIRCRESAHA.118.313276.
• 6 AWMF Leitlinie 015/018: S2k-Leitlinie: Diagnostik und Therapie hypertensiver Schwangerschaftserkrankungen. Im Internet: https://www.awmf.org/uploads/tx_szleitlinien/015-018l_S2k_Diagnostik_Therapie_hypertensiver_Schwangerschaftserkrankungen_2019-07.pdf Stand: 13.06.2022
• 7 Amraei R, Rahimi N. COVID-19, Renin-Angiotensin System and Endothelial Dysfunction. Cells 2020; 9: 1652 DOI: 10.3390/cells9071652.
• 8 Giardini V, Carrer A, Casati M. et al. Increased sFLT-1/PlGFratio in COVID-19: A novel link to angiotensin II-mediated endothelial dysfunction. Am J Hematol 2020; 95: E188-E191 DOI: 10.1002/ajh.25882.
• 9 Zeisler H, Llurba E, Chantraine F. et al. Predictive Value of the sFlt-1:PlGF Ratio in Women with Suspected Preeclampsia. N Engl J Med 2016; 374: 13-22 DOI: 10.1056/NEJMoa1414838.
• 10 McDermott M, Miller EC, Rundek T. et al. Preeclampsia: Association With Posterior Reversible Encephalopathy Syndrome and Stroke. Stroke 2018; 49: 524-530 DOI: 10.1161/STROKEAHA.117.018416.
• 11 Santos M, de Sousa DA. Cerebrovascular disease in pregnancy and postpartum. Curr Opin Neurol 2022; 35: 31-38 DOI: 10.1097/WCO.0000000000001005.
• 12 Iftikhar S, Rehman AU, Ameer MZ. et al. The association of posterior reversible encephalopathy syndrome with COVID-19: A systematic review. Ann MedSurg (Lond) 2021; 72: 103080 DOI: 10.1016/j.amsu.2021.103080.
• 13 Shankar V, Dhar P, George J. et al. Eclampsia and posterior reversible encephalopathy syndrome in a parturient complicated by SARS COVID-19 pneumonia. Braz J Anesthesiol 2021; 71: 576-578 DOI: 10.1016/j.bjane.2021.06.008.
• 14 Poggiali E, Morelli N, Terracciano C. et al. Not all is COVID19: a case of eclampsia and posterior reversible encephalopathy syndrome in the emergency room. Acta Biomed 2021; 92: e2021117 DOI: 10.23750/abm.v92iS1.11017.
• 15 Gewirtz AN, Gao V, Parauda SC. et al. Posterior Reversible Encephalopathy Syndrome. CurrPainHeadache Rep 2021; 25: 19 DOI: 10.1007/s11916-020-00932-1.
• 16 Matthaei J, Roth C. Posteriores reversibles Enzephalopathiesyndrom. DGNeurologie 2019; 2: 49-57 DOI: 10.1007/s42451-018-0035-1.
• 17 AWMF S2K Leitlinie Registernummer 015–092 „Sars-CoV-2 in der Schwangerschaft, Geburt und Wochenbett“ https://www.awmf.org/leitlinien/detail/ll/015-092.html
• 18 Wei SQ, Bilodeau-Bertrand M, Liu S. et al. The impact of COVID-19 on pregnancy outcomes: a systematic review and meta-analysis. CMAJ 2021; 193: E540-E548 DOI: 10.1503/cmaj.202604.
• 19 Mohamed MMB, Velez JCQ. Proteinuria in COVID-19. Clinical Kidney Journal 2021; 14: i40-i47 DOI: 10.1093/ckj/sfab036.
• 20 Gunduz ZB. Venous sinus thrombosis during COVID-19 infection in pregnancy: a case report. Sao Paulo Med J 2021; 139: 190-195 DOI: 10.1590/1516-3180.2020.0659.R1.08122020.
• 21 Dakay K, Cooper J, Bloomfield J. et al. Cerebral Venous Sinus Thrombosis in COVID-19 Infection: A Case Series and Review of The Literature. J Stroke Cerebrovasc Dis 2021; 30: 105434 DOI: 10.1016/j.jstrokecerebrovasdis.2020.105434.
• 22 López Pérez V, Cora Vicente J, Echevarría Granados C. et al. Postpartum consciousness disturbance: can covid-19 cause posterior reversible encephalopathy syndrome?. Rev Esp Anestesiol Reanim (Engl Ed) 2020; 67: 511-515 DOI: 10.1016/j.redar.2020.06.008.
• 23 Sripadma PV, Rai A, Wadhwa C. Postpartum Atypical Posterior Reversible Encephalopathy Syndrome in a COVID-19 Patient – An Obstetric Emergency. J Stroke Cerebrovasc Dis 2020; 29: 105357 DOI: 10.1016/j.jstrokecerebrovasdis.2020.105357.
• 24 Shankar V, Dhar P, George J. et al. Eclampsia and posterior reversible encephalopathy syndrome in a parturient complicated by SARS COVID-19 pneumonia. Braz J Anesthesiol 2021; 71: 576-578 DOI: 10.1016/j.bjane.2021.06.008.
• 25 Poggiali E, Morelli N, Terracciano C. et al. Not all is COVID19: a case of eclampsia and posterior reversible encephalopathy syndrome in the emergency room. Acta Biomed 2021; 92: e2021117 DOI: 10.23750/abm.v92iS1.11017.
• 26 Jamieson DJ, Rasmussen SA. An update on COVID-19 and pregnancy. Am J Obstet Gynecol 2022; 226: 177-186 DOI: 10.1016/j.ajog.2021.08.054.
• 27 Aghaamoo S, Ghods K, Rahmanian M. Pregnant women with COVID-19: the placental involvement and consequences. J Mol Histol 2021; 52: 427-435 DOI: 10.1007/s10735-021-09970-4.
• 28 Bouachba A, Allias F, Nadaud B. et al. Placental lesions and SARS-Cov-2 infection: Diffuse placenta damage associated to poor fetal outcome. Placenta 2021; 112: 97-104 DOI: 10.1016/j.placenta.2021.07.288.
• 29 Han M, Liu D, Zeb S. et al. Are maternal and neonatal outcomes different in placental abruption between women with and without preeclampsia?. Placenta 2019; 85: 69-73 DOI: 10.1016/j.placenta.2019.07.003.
• 30 Bertero L, Borella F, Botta G. et al. Placenta histopathology in SARS-CoV-2 infection: analysis of a consecutive series and comparison with control cohorts. Virchows Arch 2021; 479: 715-728 DOI: 10.1007/s00428-021-03097-3.
• 31 Ozer E, Cagliyan E, Yuzuguldu RI. et al. Villitis of Unknown Etiology in the Placenta of a Pregnancy Complicated by COVID-19. Turk Patoloji Derg 2021; 37: 167-171 DOI: 10.5146/tjpath.2020.01506.
• 32 de Medeiros KS, Sarmento ACA, Costa APF. et al. Consequences and implications of the coronavirus disease (COVID-19) on pregnancy and newborns: A comprehensive systematic review and meta-analysis. Int J Gynaecol Obstet 2022; 156: 394-405 DOI: 10.1002/ijgo.14015.
• 33 Mirbeyk M, Saghazadeh A, Rezaei N. A systematic review of pregnant women with COVID-19 and their neonates. Arch Gynecol Obstet 2021; 304: 5-38 DOI: 10.1007/s00404-021-06049-z.
• 34 Mand N, Iannaccone A, Longardt A. et al. Neonatal outcome following maternal infection with SARS-CoV-2 in Germany: COVID-19-Related Obstetric and Neonatal Outcome Study (CRONOS). Archives of Disease in Childhood – Fetal and Neonatal Edition. Published Online First 2021; DOI: 10.1136/archdischild-2021-322100.
• 35 Kleinwechter H, Groten T, Schäfer-Graf U. et al. CRONOS-Netzwerk. COVID-19 und Schwangerschaft: Fallserie mit der Komorbidität Diabetes aus der Registerstudie „Covid-19 Related Obstetric and Neonatal Outcome Study“ (CRONOS) [COVID-19 and pregnancy: Case series with diabetes co-morbidity from the registry study ‘Covid-19 Related Obstetric and Neonatal Outcome Study‘ (CRONOS)]. Diabetologe 2021; 17: 88-94 German DOI: 10.1007/s11428-020-00701.
• 36 Pecks U, Kuschel B, Mense L. et al. CRONOS Network. Pregnancy and SARS-CoV-2 Infection in Germany-the CRONOS Registry. DtschArztebl Int 2020; 117: 841-842 DOI: 10.3238/arztebl.2020.0841.
• 37 ItOSS COVID-19 Working Group. Coronavirus and birth in Italy: results of a national population-based cohortstudy. Ann Ist Super Sanita 2020; 56: 378-389 DOI: 10.4415/ANN_20_03_17.
• 38 Afshar Y, Gaw SL, Flaherman VJ. et al. Clinical Presentation of Coronavirus Disease 2019 (COVID-19) in Pregnant and Recently Pregnant People. ObstetGynecol 2020; 136: 1117-1125 DOI: 10.1097/AOG.0000000000004178.
• 39 Haas EJ, Angulo FJ, McLaughlin JM. et al. Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data. Lancet. 2021; 397: 1819-1829 DOI: 10.1016/S0140-6736(21)00947-8.